Lineage Cell Therapeutics Inc

Healthcare · Biotechnology

0.9475$ -2.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Lineage Cell Therapeutics Inc (LCTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 106 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LCTX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	106	101	108	103	97	113	112	91	90	113	110	106
Current Assets	43	38	46	40	34	51	50	44	42	59	56	53
Cash	31	35	44	30	28	46	48	42	40	41	36	37
Cash & Short-Term Investments	41	35	44	38	33	48	48	42	40	56	53	51
Receivables	0.4	0.7	0.1	0.2	0.4	0.6	0.2	0.3	0.1	1.6	0.8	0.8
Goodwill	11	11	11	11	11	11	11	11	11	11	11	11
Intangible Assets	47	47	47	47	47	47	47	32	32	32	32	32
Total Liabilities	39	39	37	36	32	36	34	44	69	69	57	46
Current Liabilities	16	18	17	15	14	14	13	11	9.4	11	8.1	8.0
Short-Term Debt	0.9	0.9	1.1	1.1	1.1	1.2	1.2	1.0	1.1	0.9	0.9	1.0
Accounts Payable	2.4	2.1	2.2	2.4	1.6	1.2	2.0	1.5	1.5	2.3	5.6	1.5
Shareholders' Equity	68	63	72	68	66	78	79	48	22	45	54	61
Retained Earnings	-380	-385	-391	-397	-400	-403	-408	-438	-468	-467	-472	-470
Shares Outstanding	175	173	183	189	189	200	226	228	229	230	261	261

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings